These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3910097)

  • 1. Reaction of serine proteases with substituted 3-alkoxy-4-chloroisocoumarins and 3-alkoxy-7-amino-4-chloroisocoumarins: new reactive mechanism-based inhibitors.
    Harper JW; Powers JC
    Biochemistry; 1985 Dec; 24(25):7200-13. PubMed ID: 3910097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism-based isocoumarin inhibitors for trypsin and blood coagulation serine proteases: new anticoagulants.
    Kam CM; Fujikawa K; Powers JC
    Biochemistry; 1988 Apr; 27(7):2547-57. PubMed ID: 3164217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotinylated isocoumarins, new inhibitors and reagents for detection, localization, and isolation of serine proteases.
    Kam CM; Abuelyaman AS; Li Z; Hudig D; Powers JC
    Bioconjug Chem; 1993; 4(6):560-7. PubMed ID: 8305526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reaction of porcine pancreatic elastase with 7-substituted 3-alkoxy-4-chloroisocoumarins: design of potent inhibitors using the crystal structure of the complex formed with 4-chloro-3-ethoxy-7-guanidinoisocoumarin.
    Powers JC; Oleksyszyn J; Narasimhan SL; Kam CM
    Biochemistry; 1990 Mar; 29(12):3108-18. PubMed ID: 2337582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reaction of serine proteases with substituted isocoumarins: discovery of 3,4-dichloroisocoumarin, a new general mechanism based serine protease inhibitor.
    Harper JW; Hemmi K; Powers JC
    Biochemistry; 1985 Apr; 24(8):1831-41. PubMed ID: 3893537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism-based isocoumarin inhibitors for serine proteases: use of active site structure and substrate specificity in inhibitor design.
    Powers JC; Kam CM; Narasimhan L; Oleksyszyn J; Hernandez MA; Ueda T
    J Cell Biochem; 1989 Jan; 39(1):33-46. PubMed ID: 2654146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism-based isocoumarin inhibitors for human leukocyte elastase. Effect of the 7-amino substituent and 3-alkoxy group in 3-alkoxy-7-amino-4-chloroisocoumarins on inhibitory potency.
    Kerrigan JE; Oleksyszyn J; Kam CM; Selzler J; Powers JC
    J Med Chem; 1995 Feb; 38(3):544-52. PubMed ID: 7853347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coumarin and isocoumarin as serine protease inhibitors.
    Pochet L; Frédérick R; Masereel B
    Curr Pharm Des; 2004; 10(30):3781-96. PubMed ID: 15579071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Chloroisocoumarins as Chlamydial Protease Inhibitors and Anti-Chlamydial Agents.
    Phillips MJA; Huston WM; McDonagh AM; Rawling T
    Molecules; 2024 Mar; 29(7):. PubMed ID: 38611800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active site mapping of the serine proteases human leukocyte elastase, cathepsin G, porcine pancreatic elastase, rat mast cell proteases I and II. Bovine chymotrypsin A alpha, and Staphylococcus aureus protease V-8 using tripeptide thiobenzyl ester substrates.
    Harper JW; Cook RR; Roberts CJ; McLaughlin BJ; Powers JC
    Biochemistry; 1984 Jun; 23(13):2995-3002. PubMed ID: 6380580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of new 3-alkoxy-7-amino-4-chloro-isocoumarin derivatives as new beta-amyloid peptide production inhibitors and their activities on various classes of protease.
    Bihel F; Quéléver G; Lelouard H; Petit A; Alvès da Costa C; Pourquié O; Checler F; Thellend A; Pierre P; Kraus JL
    Bioorg Med Chem; 2003 Jul; 11(14):3141-52. PubMed ID: 12818677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The function of lymphocyte proteases. Inhibition and restoration of granule-mediated lysis with isocoumarin serine protease inhibitors.
    Hudig D; Allison NJ; Pickett TM; Winkler U; Kam CM; Powers JC
    J Immunol; 1991 Aug; 147(4):1360-8. PubMed ID: 1869829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics and mechanism of human leukocyte elastase inactivation by ynenol lactones.
    Copp LJ; Krantz A; Spencer RW
    Biochemistry; 1987 Jan; 26(1):169-78. PubMed ID: 3548814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins.
    Odake S; Kam CM; Narasimhan L; Poe M; Blake JT; Krahenbuhl O; Tschopp J; Powers JC
    Biochemistry; 1991 Feb; 30(8):2217-27. PubMed ID: 1998680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human leukocyte elastase, cathepsin G, chymotrypsin A alpha, and porcine pancreatic elastase with substituted isobenzofuranones and benzopyrandiones.
    Hemmi K; Harper JW; Powers JC
    Biochemistry; 1985 Apr; 24(8):1841-8. PubMed ID: 3848330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism-based isocoumarin inhibitors for blood coagulation serine proteases. Effect of the 7-substituent in 7-amino-4-chloro-3-(isothioureidoalkoxy)isocoumarins on inhibitory and anticoagulant potency.
    Kam CM; Kerrigan JE; Plaskon RR; Duffy EJ; Lollar P; Suddath FL; Powers JC
    J Med Chem; 1994 Apr; 37(9):1298-306. PubMed ID: 8176707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel inactivators of serine proteases based on 6-chloro-2-pyrone.
    Westkaemper RB; Abeles RH
    Biochemistry; 1983 Jun; 22(13):3256-64. PubMed ID: 6411120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reaction of human skin chymotrypsin-like proteinase chymase with plasma proteinase inhibitors.
    Schechter NM; Sprows JL; Schoenberger OL; Lazarus GS; Cooperman BS; Rubin H
    J Biol Chem; 1989 Dec; 264(35):21308-15. PubMed ID: 2592376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian tissue trypsin-like enzymes: substrate specificity and inhibitory potency of substituted isocoumarin mechanism-based inhibitors, benzamidine derivatives, and arginine fluoroalkyl ketone transition-state inhibitors.
    Kam CM; Hernandez MA; Patil GS; Ueda T; Simmons WH; Braganza VJ; Powers JC
    Arch Biochem Biophys; 1995 Feb; 316(2):808-14. PubMed ID: 7864637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate specificity and inhibitors of a capillary injury-related protease from sheep lung lymph.
    Orlowski M; Lesser M; Ayala J; Lasdun A; Kam CM; Powers JC
    Arch Biochem Biophys; 1989 Feb; 269(1):125-36. PubMed ID: 2916836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.